共 50 条
- [1] Long-Term Phase 2 Efficacy of the MASP-2 Inhibitor Narsoplimab for Treatment of Severe IgA Nephropathy [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B10 - B10
- [2] Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy [J]. KIDNEY INTERNATIONAL REPORTS, 2020, 5 (11): : 2032 - 2041
- [4] Atrasentan for the Treatment of IgA Nephropathy: Interim Results From the AFFINITY Study [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 187 - 187
- [9] Updated Interim Results of a Phase 1/2 Study of BION-1301 in Patients With IgA Nephropathy [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 503 - 503